Image Credit: STAT News
STAT+: Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug
Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in the weight loss field